Peptide record

TPDB45778

Antiviral standard
9 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB45778
Antiviral
Anti-infective peptides
DRAVP 2.0
standard
No
A 9-aa standard-residue antiviral peptide sequence curated from DRAVP 2.0, with an available 3D structural model.
Sequence
VIGVGDSAL
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C36H63N9O13
RNCEQHKMFPTWY
GV
829.95
3.10
0
1
5
-1
-1.05
1.489
162.22
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
1
Residue Composition
number
1
A
0
R
0
N
1
D
0
C
0
E
0
Q
2
G
0
H
1
I
1
L
0
K
0
M
0
F
0
P
1
S
0
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 1 C: 0 E: 0 Q: 0 G: 2 H: 0 I: 1 L: 1 K: 0 M: 0 F: 0 P: 0 S: 1 T: 0 W: 0 Y: 0 V: 2
Chemical Descriptors
9 reviewed residue count
C36H63N9O13 sequence-only estimate (linear, free termini)
829.95 sequence-only estimate (linear, free termini)
3.10 sequence-only estimate (linear, free termini)
-1 sequence-only estimate (linear, free termini)
-1.05 sequence-only estimate (linear, free termini)
1.489 sequence-only estimate (linear, free termini)
Evidence Records 1 records
Evidence 1 Activity

Source & Reference

DRAVP 2.0